Demographics of heart failure (HF) patients show that they represent age 65 years and older. Heart Failure Society of America (HFSA) confirmed that the HF has the highest hospital readmission rates, high rate of physician visits each year, and more than half of them die within five years of diagnosis [1] . Aging is associated with increasing comorbidities specifically cardiac and kidney disorders due to multifactorial including hemodynamic alterations and neurohormonal activation [2] . This condition contributes to increased mortality and difficult recovery. Having an insight into the blood flow and pressure helps to correlate the mechanical conditions with the pathological changes [3]. In addition, the level of serum creatinine in the blood is a useful guide to kidney function estimated as the glomerular filtration rate (GFR). Biosensors provide an accurate and rapid assessment of small-scaled hemodynamic as an alternative to the time consuming, complicated and expensive laboratory tests, magnetic resonance imaging, and ultrasound, which can further help in preventing renal or cardio impairment [4] .
